Abstract:Abstract. This study was conducted to evaluate pregnant women's awareness of sickle cell disease and sickle cell trait and the factors that contribute to it. Two hundred and six pregnant women with at least 20 weeks gestation answered a questionnaire regarding awareness of their trait status and questions to test their knowledge of sickle cell disease. Although the majority of patients were aware of their trait status (87.4%), only 29% of knowledge questions were answered correctly; patients who self-identifie… Show more
“…27 Although complex, the HbAS variant offers a protective advantage to infections common in our set up, such as infection with Plasmodium species, 6 , 28 – 30 and this risked 25% of the next generation to acquire HbSS if genetic counseling and testing is not emphasized. 21 , 22 Further, findings from our study have indicated an information gap regarding the existence of the sickle cell defects, similar to what has been reported by other studies. 7 , 9 , 10 Lack of awareness may portend the effort to lessen the risk of genetic cross-over that could multiply the trait incidence as well as the number of individuals who may inherit the sickle cell disease.…”
PurposeTo evaluate the occurrence of sickle cell trait (SCT), assess patient awareness and evaluate the performance of a sickle cell hemoglobin-S (dithionate-qualitative solubility) point-of-care test among patients seeking care at Magale Health Center IV, Namisindwa District, Eastern Uganda.Materials and methodsWe conducted a cross sectional study, in which we consecutively enrolled participants aged ≥18 years at Magale Health Center IV. Four milliliters of EDTA blood were collected by venipuncture and screened for SCT using solubility testing, and confirmed with hemoglobin (Hb) electrophoresis at Central Public Health Laboratory (CPHL), Kampala, Uganda. A structured questionnaire was used to assess participants’ awareness of SCT. Data were presented as proportion, and measurements of diagnostic test performance were calculated.ResultsWe enrolled 242 participants, of these 58.7% (N = 142) were females. Their mean age was 26.4 years (range 18–49). Of the 242 participants, 11, who represent 4.5% (95% CI: 3.3–5.9), tested positive. The sensitivity, specificity, positive predictive value and negative predictive value of the rapid sickle cell test were 63.64%, 100%, 100% and 98.30%, respectively. There was knowledge gap regarding sickle cell awareness.ConclusionThe occurrence of SCT was high, and the point-of-care test showed a high diagnostic reliability. The risk of SCT is associated with genetic predisposition as indicated by Hb electrophoresis. Community sensitization is key to avert the associated risk of Hb defects.
“…27 Although complex, the HbAS variant offers a protective advantage to infections common in our set up, such as infection with Plasmodium species, 6 , 28 – 30 and this risked 25% of the next generation to acquire HbSS if genetic counseling and testing is not emphasized. 21 , 22 Further, findings from our study have indicated an information gap regarding the existence of the sickle cell defects, similar to what has been reported by other studies. 7 , 9 , 10 Lack of awareness may portend the effort to lessen the risk of genetic cross-over that could multiply the trait incidence as well as the number of individuals who may inherit the sickle cell disease.…”
PurposeTo evaluate the occurrence of sickle cell trait (SCT), assess patient awareness and evaluate the performance of a sickle cell hemoglobin-S (dithionate-qualitative solubility) point-of-care test among patients seeking care at Magale Health Center IV, Namisindwa District, Eastern Uganda.Materials and methodsWe conducted a cross sectional study, in which we consecutively enrolled participants aged ≥18 years at Magale Health Center IV. Four milliliters of EDTA blood were collected by venipuncture and screened for SCT using solubility testing, and confirmed with hemoglobin (Hb) electrophoresis at Central Public Health Laboratory (CPHL), Kampala, Uganda. A structured questionnaire was used to assess participants’ awareness of SCT. Data were presented as proportion, and measurements of diagnostic test performance were calculated.ResultsWe enrolled 242 participants, of these 58.7% (N = 142) were females. Their mean age was 26.4 years (range 18–49). Of the 242 participants, 11, who represent 4.5% (95% CI: 3.3–5.9), tested positive. The sensitivity, specificity, positive predictive value and negative predictive value of the rapid sickle cell test were 63.64%, 100%, 100% and 98.30%, respectively. There was knowledge gap regarding sickle cell awareness.ConclusionThe occurrence of SCT was high, and the point-of-care test showed a high diagnostic reliability. The risk of SCT is associated with genetic predisposition as indicated by Hb electrophoresis. Community sensitization is key to avert the associated risk of Hb defects.
“…Among the 300 participants who were screened for SCD, none knew of her SCD status prior to screening in the current study, including one participant who was found to be Hb-SS. This level of knowledge of personal SCD status is very low compared to that reported by Obed et al in Ghana where 10% of pregnant women self-reported sickle cell trait, and that reported by Treadwell et al where 16% reported knowledge of their sickle cell trait status ( Treadwell et al, 2006 ; Obed et al, 2017b ). Also, in a study of 147 African-American patients aged 18–50 years seen in an emergency department, 31% knew of their own trait status ( Burnham-Marusich et al, 2016 ).…”
Section: Discussionmentioning
confidence: 60%
“…This was again the same as other studies conducted in Nigeria which showed that higher level of education and knowing a relative with SCD or sickle cell trait was significantly associated with high knowledge of SCD (disease; Ezenwosu et al, 2021 ). Another study done by Obed et al showed that respondents with at least secondary education scored an average one point higher on the knowledge test than those with lower education, and knowing someone with SCD was associated with a higher level of knowledge than in individuals who did not know any affected individual ( Obed et al, 2017b ).…”
Section: Discussionmentioning
confidence: 99%
“…We expressed the descriptive statistics such as participant characteristics in frequencies and presented in tables. We graded the level of knowledge depending on the number of correct responses scored from the questionnaires which was constructed from different literature which assessed the level of knowledge on SCD in different groups including pregnant women, also modified to fit the local context ( Babalola et al, 2019 ; Obed et al, 2017a ; Al-Qattan et al, 2019 ). A correct answer was scored as “1” while a wrong response was scored as “0”.…”
Background: Sickle cell disease (SCD) is the single most important genetic cause of childhood mortality globally. Newborn screening (NBS) is the recommended intervention aimed at early identification of babies with SCD and their linkage to care. To ensure success of NBS, pregnant women need to have the required knowledge on SCD and therefore motivation to screen their babies.Objective: The aim of this study was to determine the prevalence of hemoglobin-S and assess the baseline level of knowledge on SCD among pregnant women attending antenatal clinics in urban settings in Dar-es-Salaam, Tanzania.Methods: This cross-sectional study was conducted between August 2020 and February 2021, involving 600 pregnant women at 20–28 weeks of gestation attending antenatal clinics at Buguruni Health Center, Mbagala Hospital, and Sinza Hospital in Dar-es-Salaam, Tanzania. We administered a structured questionnaire to all participants to assess socio-demographic characteristics and baseline level of knowledge on SCD, where those scoring 7 or higher out of 10 questions were considered to have good knowledge. We screened for SCD a total of 300 participants from two centers (Buguruni Health Center and Mbagala Hospital) by using Sickle SCAN point-of-care test (BioMedomics Inc., United States). We used SPSS version 23 to analyze the data. On determining the association between level of knowledge and socio-demographic factors, we used Pearson’s Chi-square and multivariate logistic regression in ascertaining the strength of associations.Results: Of the 600 participants, the majority were of the age between 26 and 35 years (51%), with the parity of 1-3 children (55.8%) and secondary level of education (43%), while 56% were self-employed. Only 14.7% had good knowledge on SCD. The majority of the participants had ever heard of SCD (81.3%), most of them heard from the streets (42.4%), and only 2.4% heard from hospitals. Of all 600 study participants, only 2 (0.3%) knew their SCD status while 7.7% declared having a family history of SCD. A proficient level of knowledge on SCD is associated with a high level of education, occupation, and knowing personal status of SCD. Among 300 participants who were screened for SCD, 252 were Hb-AA (84%), 47 were Hb-AS (15.7%), and 1 (0.3%) was Hb-SS.Conclusion: Despite the high prevalence of hemoglobin-S among pregnant women attending antenatal clinics in urban settings in Tanzania, there is a poor level of knowledge on SCD and personal knowledge of SCD status. Maternal screening and health education on SCD should be included as part of the comprehensive package for health promotion at antenatal clinics.
“…Education is particularly important when programs and ideas are new and in relatively low literacy settings. A number of studies in various settings in Africa have demonstrated the lack of knowledge about NBS and the specific diseases screened, not only among parents (Obed et al 2017;Aderotoye-Oni et al 2018) but also among health professionals (Adegoke et al 2018). Family advocacy experts from the US discussed not only the need for parent and professional education, but also the need for parent involvement in policyand decision-making activities related to NBS (Evans et al 2018;Forman et al 2013).…”
In an effort to explore new knowledge and to develop meaningful collaborations for improving child health, the First Pan African Workshop on Newborn Screening was convened in June 2019 in Rabat, Morocco. Participants included an informal network of newborn screening stakeholders from across Africa and global experts in newborn screening and sickle cell disease. Over 150 attendees, representing 20 countries, were present including 11 African countries. The agenda focused on newborn screening rationale, techniques, system development, implementation barriers, ongoing research, and collaborations both globally and across Africa. We provide an overview of the workshop and a description of the newborn screening activities in the 11 African countries represented at the workshop, with a focus on sickle cell disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.